Details

Autor(en) / Beteiligte

• Kaito, Satoshi
• Wada, Atsushi
• Adachi, Hiroto
• Konuma, Ryosuke
• Kishida, Yuya
• Nagata, Akihito
• Konishi, Tatsuya
• Yamada, Yuta
• Kumagai, Takuma
• Yoshifuji, Kota
• Mukae, Junichi
• Akiyama, Megumi
• Inamoto, Kyoko
• Toya, Takashi
• Igarashi, Aiko
• Najima, Yuho
• Muto, Hideharu
• Kobayashi, Takeshi
• Kakihana, Kazuhiko
• Ohashi, Kazuteru
• Sakamaki, Hisashi
• Doki, Noriko

Titel

Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation

Ist Teil von

• Annals of hematology, 2020-07, Vol.99 (7), p.1655-1665

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2020

Link zum Volltext

Quelle

SpringerNature Journals

Beschreibungen/Notizen

• Second allogeneic hematopoietic stem cell transplantation (allo-HSCT) has a low survival outcome and a high non-relapse mortality (NRM) rate which is a major obstacle to this treatment. We hypothesized that the status of malnourishment after first allo-HSCT as represented by the geriatric nutritional risk index (GNRI) could be used as a prognostic factor to determine the outcomes of second allo-HSCT. A total of 108 patients with a median age of 42 (range, 17–69) years, who received second allo-HSCT for disease recurrence after first allo-HSCT from our institution, were included in this study. Low GNRI had a significant impact on NRM at 2 years after second allo-HSCT: 56.9% in patients with GNRI ≤ 92 compared with 27.5% in patients with GNRI > 92 ( P  = 0.002). In multivariate analysis, GNRI of ≤ 92 was the only significant factor for NRM (hazard ratio [HR] 2.29, 95% confidence interval [CI] 1.15–4.56, P  = 0.018). High-risk disease status at second allo-HSCT (HR 2.74, 95% CI 1.46–5.14, P  = 0.002) and GNRI of ≤ 92 (HR 1.70, 95% CI 1.02–2.82, P  = 0.042) were identified as significant factors for overall survival (OS). A score of 1 was assigned to each factor, and the OS rate at 2 years after second allo-HSCT decreased according to the score: 53.0% in patients with score 0, 32.3% with score 1, and 2.5% with score 2 ( P  < 0.001). In conclusion, GNRI could be a useful predictor for the outcomes of second allo-HSCT. A prospective study in other cohorts is warranted to validate the findings of our study.